Interview
Varda Space's Will Bruey: Winnebago 5 landed, five capsules flown, launches booked through 2029 with bio-manufacturing focus
Feb 20, 2026 with Will Bruey
Key Points
- Varda Space Industries has booked launches through 2029, ramping from four this year to twelve annually by 2029, with five capsules already flown and Winnebago 6 launching next week.
- CEO Will Bruey says bio-manufacturing will drive the company for the next five to ten years because biological products command premium prices per kilogram, justifying spaceflight costs.
- Winnebago 5 recently landed and Winnebago 4 remains in orbit, demonstrating Varda's operational cadence for manufacturing pharmaceuticals and materials in microgravity.
Summary
Varda Space Industries has flown five capsules to date. Winnebago 5 landed a couple of weeks ago. Winnebago 4 is currently in orbit. Winnebago 6 ships to launch late next week. The company has booked launches through 2029, with a cadence of four this year, seven in 2027, ten in 2028, and twelve in 2029.
Varda will focus on bio-manufacturing for the next five to ten years. Biological products command premium prices per unit mass, which justifies the cost of spaceflight and microgravity processing. The focus delivers the highest dollar-per-kilogram value, has meaningful impact on human health, and makes economic sense.
You might also like...
Varda Space Industries raises $187M Series C to scale space-manufactured pharmaceuticals and biologics lab
Jul 10, 2025
Founders Fund's Delian Asparouhov: Varda lands first publicly traded pharma client, Jared Isaacman unveils sweeping NASA space policiesMar 24, 2026
Varda Space lands second reentry capsule in Australia, plans 4 missions in 2025 including pharma and DOD payloadsFeb 27, 2025